COVID-19 Vaccination Policies and Public Financing: An International Comparison and Implications
Bibliographic record
Abstract
COVID-19, caused by SARS-CoV-2, continues to evolve, highlighting the importance of vaccination in reducing morbidity and mortality. This study compared COVID-19 vaccination guidelines and National Immunization Program (NIP) policies across six countries—Australia, Japan, the United States, the United Kingdom, Canada, and South Korea—to assess the potential integration of COVID-19 vaccines into South Korea’s NIP. We analyzed regulatory frameworks, advisory committees, target groups, vaccine platforms, and cost-sharing mechanisms using official sources up to January 2025. Findings show that all countries maintain centralized decision-making structures and expert advisory bodies for evidence-based policies. While the U.S. recommends vaccination for all individuals over six months, other countries focus on high-risk groups, including those aged 65+, the immunocompromised, and institutionalized individuals. South Korea, Australia, Canada, and the U.K. provide free vaccines for high-risk groups, with Australia and Canada offering free vaccines to all. Japan ceased subsidies in March 2024, and in the U.S., free vaccination is mainly covered by private insurance, with limited public support. These variations reflect adjustments as COVID-19 transitions to an endemic phase, with policies shifting toward sustainability. South Korea must carefully assess whether to integrate COVID- 19 vaccines into the NIP. Future policies should ensure cost-effectiveness, vaccine supply stability, and financial sustainability amid evolving variants.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.006 | 0.016 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.001 |
| Bibliometrics | 0.002 | 0.004 |
| Science and technology studies | 0.000 | 0.001 |
| Scholarly communication | 0.002 | 0.003 |
| Open science | 0.000 | 0.002 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.003 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".